Strs Ohio Chimerix Inc Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$1.19 - $2.09 $96,390 - $169,290	81,000 New	81,000 $102,000
Q4 2022 Jan 26, 2023	BUY	$1.67 - $2.35 $59,452 - $83,660	35,600 Added 78.41%	81,000 $150,000
Q3 2022 Oct 27, 2022	BUY	$1.81 - $2.76 $82,174 - $125,303	45,400 New	45,400 $87,000
Q4 2021 Jan 24, 2022	SELL	$5.23 - $7.18 $172,590 - $236,940	-33,000 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$4.76 - $11.25 $70,448 - $166,500	14,800 Added 81.32%	33,000 $318,000
Q4 2020 Jan 25, 2021	BUY	$2.43 - $5.42 $44,226 - $98,644	18,200 New	18,200 $87,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.